BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
Clinical trial NCT01669798 · COMPLETED
Trial details
- NCT number
- NCT01669798
- Sponsor
- AA Secord
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2017-09-10
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.